Aorto-Iliac Occlusive Disease Treatment Market Size, Share, & Industry Analysis Report: By Device Type (Endovascular Devices and Surgical Devices), By Procedure, By End Use, and By Region

Description

List of Tables

The aorto-iliac occlusive disease treatment market size is expected to reach USD 3.56 billion by 2034, according to a new study by Polaris Market Research. The report "Aorto-Iliac Occlusive Disease Treatment Market Size, Share, & Industry Analysis Report: By Device Type (Endovascular Devices and Surgical Devices), By Procedure, By End Use, and By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The aorto-iliac occlusive disease treatment market addresses the medical and surgical management of arterial blockages occurring in the aorta and iliac arteries, typically caused by atherosclerosis. The increasing prevalence of chronic conditions such as diabetes, hypertension, and obesity has intensified clinical demand for both endovascular and open surgical interventions. Endovascular procedures, particularly angioplasty and stenting, have become the preferred therapeutic approach due to their lower complication rates, reduced hospital stays, and improved patient outcomes.

Market growth is supported by advancements in device technologies, including drug-eluting stents, bioresorbable scaffolds, and image-guided navigation systems, which enhance precision and long-term efficacy. Industry players are focusing on hybrid revascularization techniques to treat complex lesions and multilevel occlusions, creating new avenues for treatment optimization. There is also a rising trend toward outpatient vascular care centers, where minimally invasive interventions are being performed in high volumes. Increasing emphasis on early detection, risk stratification, and lifestyle modification programs has elevated the importance of integrated care models.

The convergence of diagnostic imaging, artificial intelligence, and vascular robotics is gradually transforming the treatment paradigm, paving the way for more personalized, data-driven interventions. Investments in clinical trials and post-market surveillance studies continue to inform device safety, durability, and performance metrics. Opportunities lie in expanding access to next-generation therapies in underserved populations and refining treatment algorithms to improve outcomes in high-risk patients. The market is steadily evolving into a more technologically enabled, outcome-focused ecosystem that emphasizes procedural efficiency, long-term patency, and patient quality of life.

Aorto-Iliac Occlusive Disease Treatment Market Report Highlights

By device type, in 2024, the endovascular devices segment captured the largest share, primarily driven by the increasing preference for minimally invasive surgery in managing aorto-iliac occlusive disease.

Based on end use, in 2024, the hospitals segment accounted for the largest share, fueled by their capacity to manage high-risk cases requiring multidisciplinary teams, advanced imaging, and surgical backup.

In 2024, the North America aorto-iliac occlusive disease treatment market accounted for the largest share due to the widespread use of advanced endovascular procedures, strong reimbursement frameworks, and early diagnosis practices.

The Asia Pacific aorto-iliac occlusive disease treatment market is projected to register the highest CAGR during the forecast period due to rising healthcare access, expanding medical infrastructure, and increasing awareness of vascular conditions.

A few global key players include Abbott; BD.; Bentley InnoMed; Biotronik SE & Co KG; Boston Scientific Corporation; Cook; Getinge AB; iVascular; Medtronic; Scitech Medical; Terumo Corporation; W. L. Gore & Associates, Inc.; and ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.

Polaris Market Research has segmented the aorto-iliac occlusive disease treatment market on the basis of device type, procedure, end use, and region:

By Device Type Outlook (Revenue, USD Billion, 2020-2034)

Endovascular Devices

Balloon Angioplasty Devices

Atherectomy Systems

Stents

Surgical Devices

By Procedure Outlook (Revenue, USD Billion, 2020-2034)

Endovascular Procedures

Hybrid Procedures

Open Surgical Procedures

By End Use Outlook (Revenue, USD Billion, 2020-2034)

Hospitals

Outpatient Facilities

Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

Canada

Europe

Germany

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Vietnam

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

Product Code: PM5750

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Aorto-Iliac Occlusive Disease Treatment Market Insights

4.1. Aorto-Iliac Occlusive Disease Treatment Market - Market Snapshot
4.2. Aorto-Iliac Occlusive Disease Treatment Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Rising Prevalence of Peripheral Arterial Disease (PAD)
  - 4.2.1.2. Growing Geriatric Population
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High Cost of Advanced Treatments
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Aorto-Iliac Occlusive Disease Treatment Market Trends
4.6. Value Chain Analysis

5. Global Aorto-Iliac Occlusive Disease Treatment Market, by Device Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
5.3. Endovascular Devices
- 5.3.1. Global Aorto-Iliac Occlusive Disease Treatment Market, by Endovascular Devices, by Region, 2020-2034 (USD Billion)
5.4. Surgical Devices
- 5.4.1. Global Aorto-Iliac Occlusive Disease Treatment Market, by Surgical Devices, by Region, 2020-2034 (USD Billion)

6. Global Aorto-Iliac Occlusive Disease Treatment Market, by Procedure

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
6.3. Endovascular Procedures
- 6.3.1. Global Aorto-Iliac Occlusive Disease Treatment Market, by Endovascular Procedures, by Region, 2020-2034 (USD Billion)
6.4. Hybrid Procedures
- 6.4.1. Global Aorto-Iliac Occlusive Disease Treatment Market, by Hybrid Procedures, by Region, 2020-2034 (USD Billion)
6.5. Open Surgical Procedures
- 6.5.1. Global Aorto-Iliac Occlusive Disease Treatment Market, by Open Surgical Procedures, by Region, 2020-2034 (USD Billion)

7. Global Aorto-Iliac Occlusive Disease Treatment Market, by End Use

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
7.3. Hospitals
- 7.3.1. Global Aorto-Iliac Occlusive Disease Treatment Market, by Hospitals, by Region, 2020-2034 (USD Billion)
7.4. Outpatient Facilities
- 7.4.1. Global Aorto-Iliac Occlusive Disease Treatment Market, by Outpatient Facilities, by Region, 2020-2034 (USD Billion)
7.5. Others
- 7.5.1. Global Aorto-Iliac Occlusive Disease Treatment Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global Aorto-Iliac Occlusive Disease Treatment Market, by Geography

8.1. Key Findings
8.2. Introduction
- 8.2.1. Aorto-Iliac Occlusive Disease Treatment Market Assessment, By Geography, 2020-2034 (USD Billion)
8.3. Aorto-Iliac Occlusive Disease Treatment Market - North America
- 8.3.1. North America: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
- 8.3.2. North America: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
- 8.3.3. North America: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
- 8.3.4. Aorto-Iliac Occlusive Disease Treatment Market - U.S.
  - 8.3.4.1. U.S.: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  - 8.3.4.2. U.S.: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  - 8.3.4.3. U.S.: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
- 8.3.5. Aorto-Iliac Occlusive Disease Treatment Market - Canada
  - 8.3.5.1. Canada: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  - 8.3.5.2. Canada: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  - 8.3.5.3. Canada: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
8.4. Aorto-Iliac Occlusive Disease Treatment Market - Europe
- 8.4.1. Europe: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
- 8.4.2. Europe: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
- 8.4.3. Europe: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
- 8.4.4. Aorto-Iliac Occlusive Disease Treatment Market - UK
  - 8.4.4.1. UK: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  - 8.4.4.2. UK: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  - 8.4.4.3. UK: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
- 8.4.5. Aorto-Iliac Occlusive Disease Treatment Market - France
  - 8.4.5.1. France: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  - 8.4.5.2. France: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  - 8.4.5.3. France: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
- 8.4.6. Aorto-Iliac Occlusive Disease Treatment Market - Germany
  - 8.4.6.1. Germany: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  - 8.4.6.2. Germany: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  - 8.4.6.3. Germany: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
- 8.4.7. Aorto-Iliac Occlusive Disease Treatment Market - Italy
  - 8.4.7.1. Italy: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  - 8.4.7.2. Italy: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  - 8.4.7.3. Italy: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
- 8.4.8. Aorto-Iliac Occlusive Disease Treatment Market - Spain
  - 8.4.8.1. Spain: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  - 8.4.8.2. Spain: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  - 8.4.8.3. Spain: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
- 8.4.9. Aorto-Iliac Occlusive Disease Treatment Market - Netherlands
  - 8.4.9.1. Netherlands: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  - 8.4.9.2. Netherlands: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  - 8.4.9.3. Netherlands: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
- 8.4.10. Aorto-Iliac Occlusive Disease Treatment Market - Russia
  - 8.4.10.1. Russia: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  - 8.4.10.2. Russia: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  - 8.4.10.3. Russia: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
- 8.4.11. Aorto-Iliac Occlusive Disease Treatment Market - Rest of Europe
  - 8.4.11.1. Rest of Europe: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  - 8.4.11.2. Rest of Europe: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  - 8.4.11.3. Rest of Europe: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
8.5. Aorto-Iliac Occlusive Disease Treatment Market - Asia Pacific
- 8.5.1. Asia Pacific: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
- 8.5.2. Asia Pacific: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
- 8.5.3. Asia Pacific: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
- 8.5.4. Aorto-Iliac Occlusive Disease Treatment Market - China
  - 8.5.4.1. China: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  - 8.5.4.2. China: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  - 8.5.4.3. China: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
- 8.5.5. Aorto-Iliac Occlusive Disease Treatment Market - India
  - 8.5.5.1. India: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  - 8.5.5.2. India: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  - 8.5.5.3. India: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
- 8.5.6. Aorto-Iliac Occlusive Disease Treatment Market - Malaysia
  - 8.5.6.1. Malaysia: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  - 8.5.6.2. Malaysia: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  - 8.5.6.3. Malaysia: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
- 8.5.7. Aorto-Iliac Occlusive Disease Treatment Market - Japan
  - 8.5.7.1. Japan: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  - 8.5.7.2. Japan: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  - 8.5.7.3. Japan: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
- 8.5.8. Aorto-Iliac Occlusive Disease Treatment Market - Indonesia
  - 8.5.8.1. Indonesia: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  - 8.5.8.2. Indonesia: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  - 8.5.8.3. Indonesia: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
- 8.5.9. Aorto-Iliac Occlusive Disease Treatment Market - South Korea
  - 8.5.9.1. South Korea: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  - 8.5.9.2. South Korea: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  - 8.5.9.3. South Korea: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
- 8.5.10. Aorto-Iliac Occlusive Disease Treatment Market - Australia
  - 8.5.10.1. Australia: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  - 8.5.10.2. Australia: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  - 8.5.10.3. Australia: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
- 8.5.11. Aorto-Iliac Occlusive Disease Treatment Market - Rest of Asia Pacific
  - 8.5.11.1. Rest of Asia Pacific: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  - 8.5.11.2. Rest of Asia Pacific: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  - 8.5.11.3. Rest of Asia Pacific: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
8.6. Aorto-Iliac Occlusive Disease Treatment Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
- 8.6.2. Middle East & Africa: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
- 8.6.3. Middle East & Africa: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
- 8.6.4. Aorto-Iliac Occlusive Disease Treatment Market - Saudi Arabia
  - 8.6.4.1. Saudi Arabia: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  - 8.6.4.2. Saudi Arabia: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  - 8.6.4.3. Saudi Arabia: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
- 8.6.5. Aorto-Iliac Occlusive Disease Treatment Market - UAE
  - 8.6.5.1. UAE: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  - 8.6.5.2. UAE: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  - 8.6.5.3. UAE: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
- 8.6.6. Aorto-Iliac Occlusive Disease Treatment Market - Israel
  - 8.6.6.1. Israel: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  - 8.6.6.2. Israel: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  - 8.6.6.3. Israel: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
- 8.6.7. Aorto-Iliac Occlusive Disease Treatment Market - South Africa
  - 8.6.7.1. South Africa: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  - 8.6.7.2. South Africa: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  - 8.6.7.3. South Africa: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
- 8.6.8. Aorto-Iliac Occlusive Disease Treatment Market - Rest of Middle East & Africa
  - 8.6.8.1. Rest of Middle East & Africa: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  - 8.6.8.2. Rest of Middle East & Africa: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  - 8.6.8.3. Rest of Middle East & Africa: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
8.7. Aorto-Iliac Occlusive Disease Treatment Market - Latin America
- 8.7.1. Latin America: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
- 8.7.2. Latin America: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
- 8.7.3. Latin America: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
- 8.7.4. Aorto-Iliac Occlusive Disease Treatment Market - Mexico
  - 8.7.4.1. Mexico: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  - 8.7.4.2. Mexico: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  - 8.7.4.3. Mexico: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
- 8.7.5. Aorto-Iliac Occlusive Disease Treatment Market - Brazil
  - 8.7.5.1. Brazil: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  - 8.7.5.2. Brazil: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  - 8.7.5.3. Brazil: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
- 8.7.6. Aorto-Iliac Occlusive Disease Treatment Market - Argentina
  - 8.7.6.1. Argentina: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  - 8.7.6.2. Argentina: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  - 8.7.6.3. Argentina: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
- 8.7.7. Aorto-Iliac Occlusive Disease Treatment Market - Rest of Latin America
  - 8.7.7.1. Rest of Latin America: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  - 8.7.7.2. Rest of Latin America: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  - 8.7.7.3. Rest of Latin America: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. Abbott
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
10.2. BD.
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
10.3. Bentley InnoMed
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
10.4. Biotronik SE & Co KG
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
10.5. Boston Scientific Corporation
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
10.6. Cook
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
10.7. Getinge AB
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
10.8. iVascular
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
10.9. Medtronic
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
10.10. Scitech Medical
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
10.11. Terumo Corporation
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
10.12. W. L. Gore & Associates, Inc.
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
10.13. ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
- 10.13.1. Company Overview
- 10.13.2. Financial Performance
- 10.13.3. Product Benchmarking
- 10.13.4. Recent Development